These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12358849)

  • 1. Definition of permissible and immunogenic HLA antigens based on epitope analysis of the HLA specific antibodies produced in sensitized patients.
    Papassavas AC; Stavropoulos-Giokas C; Boletis J; Ioannou S; Iniotaki-Theodoraki A; Kostakis A
    Eur J Immunogenet; 2002 Oct; 29(5):401-7. PubMed ID: 12358849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A limited number of HLA epitopes are recognized from HLA class I-specific antibodies detected in the serum of sensitized patients.
    Papassavas AC; Iniotaki-Theodoraki A; Boletis J; Douramani P; Kostakis A; Stavropoulos-Giokas C
    Hum Immunol; 2000 Jul; 61(7):705-10. PubMed ID: 10880741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope analysis of HLA class I donor specific antibodies in sensitized renal transplant recipients.
    Papassavas AC; Iniotaki-Theodoraki A; Boletis J; Kostakis A; Stavropoulos-Giokas C
    Transplantation; 2000 Jul; 70(2):323-7. PubMed ID: 10933158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private class I HLA determinants. Implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation.
    Duquesnoy RJ; White LT; Fierst JW; Vanek M; Banner BF; Iwaki Y; Starzl TE
    Transplantation; 1990 Sep; 50(3):427-37. PubMed ID: 2402792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
    Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
    Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients.
    Lobashevsky AL; Senkbeil RW; Shoaf JL; Stephenson AK; Skelton SB; Burke RM; Deierhoi MH; Thomas JM
    Hum Immunol; 2002 May; 63(5):364-74. PubMed ID: 11975980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies.
    Duquesnoy RJ; Marrari M
    Curr Opin Organ Transplant; 2009 Aug; 14(4):403-9. PubMed ID: 19417654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How the definition of acceptable antigens and epitope analysis can facilitate transplantation of highly sensitized patients with excellent long-term graft survival.
    Heidt S; Haasnoot GW; Claas FHJ
    Curr Opin Organ Transplant; 2018 Aug; 23(4):493-499. PubMed ID: 29846197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long and winding road towards epitope matching in clinical transplantation.
    Kramer CSM; Israeli M; Mulder A; Doxiadis IIN; Haasnoot GW; Heidt S; Claas FHJ
    Transpl Int; 2019 Jan; 32(1):16-24. PubMed ID: 30341790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there MHC Class II restriction of the response to MHC Class I in transplant patients?
    Papassavas AC; Barnardo MC; Bunce M; Welsh KI
    Transplantation; 2002 Feb; 73(4):642-51. PubMed ID: 11889447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA epitope based matching for transplantation.
    Duquesnoy RJ
    Transpl Immunol; 2014 Jun; 31(1):1-6. PubMed ID: 24769079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assignment of HLA-antigens in CREGs facilitates the detection of acceptable mismatches in highly sensitized patients.
    Papassavas AC; Iniotaki-Theodoraki A; Boletis J; Kostakis A; Stavropoulos-Giokas C
    Hum Immunol; 1998 Sep; 59(9):587-96. PubMed ID: 9757915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant.
    Resse M; Paolillo R; Casamassimi A; Cavalca F; Fiorito C; Maiello C; Napoli C
    Hum Immunol; 2013 Aug; 74(8):937-41. PubMed ID: 23628396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel aspects of epitope matching and practical application in kidney transplantation.
    Lim WH; Wong G; Heidt S; Claas FHJ
    Kidney Int; 2018 Feb; 93(2):314-324. PubMed ID: 29061333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
    Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
    Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients.
    Rodey GE; Neylan JF; Whelchel JD; Revels KW; Bray RA
    Hum Immunol; 1994 Apr; 39(4):272-80. PubMed ID: 7520897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.